Stay updated on Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial

Sign up to get notified when there's something new on the Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Version label updated from v3.4.1 to v3.4.2 in the page footer.
    Difference
    0.0%
    Check dated 2026-02-13T07:37:07.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Added a Lancet HIV 2021 96-week results publication citation with revision note (v3.4.1) and removed the Lancet HIV erratum reference with revision (v3.4.0).
    Difference
    0.0%
    Check dated 2026-02-05T14:20:57.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    UI/metadata updates were applied: a Show glossary option was added, and the page now displays a Last Update Submitted that Met QC Criteria field along with a Revision indicator (v3.4.0). The older QC Criteria label (Last Update Submitted that met QC Criteria) and the No FEAR Act data label were removed, and capitalization of FEAR Act data was adjusted.
    Difference
    0.1%
    Check dated 2026-01-29T09:43:03.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    A new 'Last Update Posted' field was added to the Study Details page. The 'Last Update Posted (Estimated)' field was removed.
    Difference
    0.0%
    Check dated 2026-01-22T05:38:19.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 deployed; no visible updates to study details, eligibility criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:22:41.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    Added Durban site (South Africa, 4091) and updated the Lancet HIV 2021 publication entry, replacing the previous Durban site (4001). Updated the page's Last Update Posted dates to December 2025.
    Difference
    0.2%
    Check dated 2026-01-07T01:37:48.000Z thumbnail image

Stay in the know with updates to Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial page.